Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations.
about
Zidovudine (AZT) monotherapy selects for the A360V mutation in the connection domain of HIV-1 reverse transcriptaseHIV behind bars: human immunodeficiency virus cluster analysis and drug resistance in a reference correctional unit from southern BrazilAnti-human immunodeficiency virus type 1 activity of novel 6-substituted 1-benzyl-3-(3,5-dimethylbenzyl)uracil derivatives.The effects of RNase H inhibitors and nevirapine on the susceptibility of HIV-1 to AZT and 3TC.Characterization of two HIV-1 infectors during initial antiretroviral treatment, and the emergence of phenotypic resistance in reverse transcriptase-associated mutation patterns.Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistanceThe connection domain mutation N348I in HIV-1 reverse transcriptase enhances resistance to etravirine and rilpivirine but restricts the emergence of the E138K resistance mutation by diminishing viral replication capacity.Biochemical characterization of a multi-drug resistant HIV-1 subtype AG reverse transcriptase: antagonism of AZT discrimination and excision pathways and sensitivity to RNase H inhibitors.Agreement between an in-house replication competent and a reference replication defective recombinant virus assay for measuring phenotypic resistance to HIV-1 protease, reverse transcriptase, and integrase inhibitors.Identification of Novel Resistance-Related Polymorphisms in HIV-1 Subtype C RT Connection and RNase H Domains from Patients Under Virological Failure in Brazil.Natural Plant Alkaloid (Emetine) Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity.Reverse transcriptase backbone can alter the polymerization and RNase activities of non-nucleoside reverse transcriptase mutants K101E+G190S.Early selection of resistance-associated mutations in HIV-1 RT C-terminal domains across different subtypes: role of the genetic barrier to resistance.Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals.Characterization of HIV-1 Near Full-Length Proviral Genome Quasispecies from Patients with Undetectable Viral Load Undergoing First-Line HAART Therapy.Role of phenotypic investigation in the era of routine genotypic HIV-1 drug resistance testing
P2860
Q28481004-A5134E4B-2630-4425-946B-C50B6D60F36BQ28534576-1D4B34E0-C72B-4D4B-AFD3-82B24630EF3CQ34145448-C63413B1-5F59-4535-9D68-6570AEE807C7Q35684111-2CFA8E48-C9C5-4435-9245-D1F553488975Q36292765-5854BBFA-B7C5-4538-88C5-FF8BAAA5AE24Q36501787-F9B06D94-12B3-4C2A-8280-BF8AEFA5F065Q37547275-503562B1-59A9-4146-BC5D-F0426982E3C3Q39142877-453DAAC2-AE0F-4B13-9C03-993A5160C463Q40288242-B1E76DA4-3BDA-4206-B680-1E631796D82FQ40440258-469A2C73-9A32-41B4-9EA1-D2CBDE710E18Q41140055-3C4D5CEB-9502-4D20-8F83-8E756BB836D9Q42159090-0B4B195B-EFCD-440E-A7FB-8446F669CB60Q42211133-3FA18AAD-1838-486F-8EAC-1569600D93CFQ46939003-78F1EF65-EC15-41F9-B4C5-A6B9F716F507Q47140686-06C6D5F9-9465-4592-9EB7-2B0EED034AD3Q56792140-3B7B1C87-6385-4C75-9D94-FA80FE9EBB7F
P2860
Phenotypic characterization of drug resistance-associated mutations in HIV-1 RT connection and RNase H domains and their correlation with thymidine analogue mutations.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phenotypic characterization of ...... thymidine analogue mutations.
@ast
Phenotypic characterization of ...... thymidine analogue mutations.
@en
Phenotypic characterization of ...... thymidine analogue mutations.
@nl
type
label
Phenotypic characterization of ...... thymidine analogue mutations.
@ast
Phenotypic characterization of ...... thymidine analogue mutations.
@en
Phenotypic characterization of ...... thymidine analogue mutations.
@nl
prefLabel
Phenotypic characterization of ...... thymidine analogue mutations.
@ast
Phenotypic characterization of ...... thymidine analogue mutations.
@en
Phenotypic characterization of ...... thymidine analogue mutations.
@nl
P2093
P2860
P356
P1476
Phenotypic characterization of ...... h thymidine analogue mutations
@en
P2093
André F Santos
Galina N Nikolenko
Jessica Baumann
Krista A Delviks-Frankenberry
Marcelo A Soares
Renan B Lengruber
P2860
P304
P356
10.1093/JAC/DKR005
P407
P577
2011-01-26T00:00:00Z